IL-2 is essential for TGF-β to convert naive CD4+CD25 - cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells

Journal of Immunology

Volumn 178, Issue 4, 2007, Pages 2018-2027

  Song, Guo Zheng ^a   Wang, Juhua ^a   Wang, Pu ^a,b   Gray, J Dixon ^a   Horwitz, David A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Western Medicine Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

EID: 33846923124     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.4.2018     Document Type: Article

References (63)

1. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
2. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16: 81-88.
3. Thompson, C., and F. Powrie. 2004. Regulatory T cells. Curr. Opin. Pharmacol. 4: 408-414.
4. + regulatory T cells. Int. Immunol. 16: 1643-1656.
5. + regulatory T cells. Nat. Immunol. 4: 330-336.
6. + T regulatory cells. Nat. Immunol. 4: 337-342.
7. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
8. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J. Immunol. 172: 5213-5221.
9. - precursors. Am. J. Transplant. 4: 1614-1627.
10. Rao, P. E., A. L. Petrone, and P. D. Ponath. 2005. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J. Immunol. 174: 1446-1455.
11. - T cells. Int. Immunol. 16: 1203-1213.
12. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153..
13. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196: 237-246.
14. + regulatory T cell function. Eur. J. Immunol. 34: 2996-3005.
15. Tai, X., M. Cowan, L. Feigenbaum, and A. Singer. 2005. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6: 152-162.
16. + regulatory cells. J. Immunol. 176: 3321-3329.
17. Li, M. O., Y. Y. Wan, S. Sanjabi, A. K. Robertson, and R. A. Flavell. 2006. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24: 99-146.
18. + T and NK cells. J. Exp. Med. 180: 1937-1942.
19. + regulatory T cells from human peripheral blood. J. Immunol. 166: 7282-7289.
20. - precursors. J. Immunol. 169: 4183-4189.
21. + regulatory T cells. J. Exp. Med. 201: 1061-1067.
22. + regulatory T cells. J. Exp. Med. 201: 737-746.
23. Smith, K. A. 1988. Interleukin-2: inception, impact, and implications. Science 240: 1169-1176.
24. Malek, T. R., and A. L. Bayer. 2004. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4: 665-674.
25. Nelson, B. H. 2004. IL-2, regulatory T cells, and tolerance. J. Immunol. 172: 3983-3988.
26. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
27. Malek, T. R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice: implications for the nonredundant function of IL-2. Immunity 17: 167-178.
28. Papiernik, M., M. L. de Moraes, C. Pontoux, F. Vasseur, and C. Penit. 1998. Regulatory CD4 T cells: expression of IL-2Rα chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10: 371-378.
29. + T cell numbers. J. Immunol. 169: 4850-4860.
30. + regulatory T cell function. J. Exp. Med. 196: 851-857.
31. + regulatory T cells by interleukin IL-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201: 723-735.
32. + regulatory T cells by peripheral expansion. J. Immunol. 173: 7259-7268.
33. + T regulatory cell development during the neonatal period. J. Exp. Med. 201: 769-777.
34. + T cell suppressor function. J. Immunol. 172: 6519-6523.
35. + regulatory T cell function. Eur. J. Immunol. 34: 2480-2488.
36. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6: 1152-1159.
37. Antony, P. A., C. M. Paulos, M. Ahmadzadeh, A. Akpinarli, D. C. Palmer, N. Sato, A. Kaiser, C. Heinrichs, C. A. Klebanoff, Y. Tagaya, and N. P. Restifo. 2006. Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J. Immunol. 176: 5255-5266.
38. + regulatory T cell subsets. J. Leukocyte Biol. 74: 471-478.
39. + regulatory T cells generated ex vivo with IL-2 and TGF-β suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 172: 1531-1539.
40. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
41. + T lymphocytes. Int. Immunol. 6: 631-638.
42. Knoechel, B., J. Lohr, E. Kahn, J. A. Bluestone, and A. K. Abbas. 2005. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202: 1375-1386.
43. + regulatory T cells through a STAT dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-1579.
44. + regulatory T cells in inflamed synovia. J. Exp. Med. 201: 1793-1803.
45. Kim, H. P., B. G. Kim, J. Letterio, and W. J. Leonard. 2005. Smad-dependent cooperative regulation of interleukin-2 receptor α chain gene expression by T cell receptor and TGF-β. J. Biol. Chem. 280: 34042-34047.
46. Fox, F. E., H. C. Ford, R. Douglas, S. Cherian, and P. C. Nowell. 1993. Evidence that TGF-β can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms. Cell. Immunol. 150: 45-58.
47. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production. J. Immunol. 160: 5719-5728.
48. Huse, M., B. F. Lillemeier, M. S. Kuhns, D. S. Chen, and M. M. Davis. 2006. T cells use two directionally distinct pathways for cytokine secretion. Nat. Immunol. 7: 247-255.
49. Zhang, X., L. Giangreco, H. E. Broome, C. M. Dargan, and S. L. Swain. 1995. Control of CD4 effector fate: transforming growth factor β1 and inferleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp. Med. 182: 699-709.
50. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163: 1037-1050.
51. Nykjaer, A., B. Moller, R. F. Todd, T. Christensen, P. A. Andreasen, J. Gliemann, and C. M. Petersen. 1994. Urokinase receptor: an activation antigen in human T lymphocytes. J. Immunol. 152: 505-516.
52. Odekon, L. E., F. Blasi, and D. B. Rifkin. 1994. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J. Cell. Physiol. 158: 398-407.
53. Nelson, B. H., T. P. Martyak, L. J. Thompson, J. J. Moon, and T. Wang. 2003. Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-β signaling. J. Immunol. 170: 5563-5570.
54. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 12: 1219-1227.
55. Dauphinee, M. J., S. B. Kipper, D. Wofsy, and N. Talal. 1981. Interleukin 2 deficiency is a common feature of autoimmune mice. J. Immunol. 127: 2483-2487.
56. Altman, A., A. N. Theofilopoulos, R. Weiner, D. H. Katz, and F. J. Dixon. 1981. Analysis of T cell function in autoimmune murine strains: defects in production and responsiveness to interleukin 2. J. Exp. Med. 154: 791-808.
57. Ohtsuka, K., J. D. Gray, M. M. Stimmler, B. Toro, and D. A. Horwitz. 1998. Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 160: 2539-2545.
58. Horwitz, D. A., W. Stohl, and J. D. Gray. 2002. T lymphocytes, natural killer cells, and immune regulation. In Dubois's Lupus Erythematosus, 6th Ed. D. J. Wallace and B. H. Hahn, eds. Lippincott Williams & Wilkins Press, Philadelphia, PA, pp. 157-185.
59. Raz, E., J. Dudler, M. Lotz, S. M. Baird, C. C. Berry, R. A. Eisenberg, and D. A. Carson, 1995. Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 4: 286-292.
60. Ohtsuka, K., J. D. Gray, F. P. Quismorio, Jr., W. Lee, and D. A. Horwitz. 1999. Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-β. Lupus 8: 95-102.
61. Crispin, J. C., A. Martinez, and J. Alcocer-Varela. 2003. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 21: 273-276.
62. + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. J. Immunol. 59: 198-202.
63. Miyara, M., Z. Amoura, C. Parizot, C. Badoual, K. Dorgham, S. Trad, D. Nochy, P. Debre, J. C. Piette, and G. Gorochov. 2005. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 175: 8392-8400.